Cohance Lifesciences is a global CDMO platform specializing in small molecule APIs, antibody-drug conjugates (ADCs), and nucleic acid chemistry, serving customers in nearly 60 countries with 80+ molecules in their portfolio. The company operates 20+ manufacturing and R&D facilities across India and the US, with multiple USFDA and EDQM-accredited sites, offering end-to-end solutions from drug discovery through commercialization including high-potent APIs (OEB 4 & 5), oligonucleotides, and finished dosage forms.
Small molecule APIs, ADC development, high-potent API manufacturing, oligonucleotide synthesis, nucleic acid chemistry, phosphoramidite chemistry
2 sites worldwide
No reviews available yet.
No documents available.